People over 18 can register for COVID-19 vaccines starting April 24

Anyone over 18 can sign up for a COVID-19 vaccine starting Saturday, April 24, 2021, said Ram Sewak Sharma, CEO of the National Health Authority. The Hindu. However, they will only get appointments after hospitals publish their schedules on CoWin, the hub site for coordinating vaccine collection.

On Monday, the Center announced that anyone over the age of 18 will be eligible for a vaccine from May.

Estimates for India’s adult population range from 800 to 900 billion and excluding those over 45 and the 130 million who have at least one dose – at least 500 to 600 million are expected to sign up for doses from of Saturday. Mr. Sharma said the Center was “improving the infrastructure” to reflect these numbers.

Unlike the current immunization campaign, where the Center is the sole purchaser and supplier of vaccines to states, the May rollout will also include doses that were independently purchased by states from vaccine manufacturers. It could also include shots of Sputnik V, the Russian vaccine cleared by the Central Drug Regulator.

However, Bharat Biotech and Serum Institute of India are meeting existing commitments to the Center and said they were unable to significantly increase supply until July. It is also not known when the first doses of Sputnik V will be available.

Under the existing system, beneficiaries can register for a vaccination window and opt for a center closest to them. There is also an option to register on site. Currently, vaccinations at private facilities are charged ₹ 250. Those in government centers will continue to receive the vaccine free of charge, the Center said Thursday. Also in the future, the Center will continue to be the purchaser of half of the approved doses of Covaxin and Covishield.

The SII said it would charge states that make deals for them ₹ 400 for a dose and private hospitals at ₹ 600 per dose. Currently he has sold, or is fulfilling orders, worth 210 million doses of vaccine at ₹ 150-180 per dose. The prices quoted by Covaxin and Sputnik V are still unknown.